EOLS Cash from Financing Activities - Cash Flow Statement - Evolus, Inc. - IntrinsicAlpha

Evolus, Inc. EOLS

Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US

$ 14.49

1.97 %

$ 918 M

Market Cap

-15.92

P/E

EOLS - CASH FROM FINANCING ACTIVITIES

Cash from Financing Activities EOLS - Evolus, Inc.

44.6 M

LAST VALUE

-21.83%

2 YEAR CAGR

-17.78%

5 YEAR CAGR

0.00%

10 YEAR CAGR